“As far as an outlook goes, look, year-to-date sales have been in line with the prior year, and we expect full year sales for Asia to be close to flat year-over-year.”

In context

“en products in Japan. And we continue to evolve this product portfolio to maintain competitiveness. So, we've introduced several new products. We launched a refreshed yen-denominated variable life product. We've launched a cancer product earlier this year. Both products have performed very well. We've also launched a refreshed A&H medical product this month, and we're planning to launch a new U.S. dollar life product early next year. If we look at the rest of Asia, what we're seeing, our sales have gone up 9% year-over-year, and that's driven primarily from China and India. Solid performance in China, especially as we look across both our channels, bancassurance as well as agency. And if you look in India, we've seen sales increase sharply there with strong growth across all our channels. As far as an outlook goes, look, year-to-date sales have been in line with the prior year, and we expect full year sales for Asia to be close to flat year-over-year. John McCallion: Jimmy, I'll take your commercial mortgage comment or question. As you pointed out, I think despite the recent pressure, we've kind of commented on a few factors, right? There's been continued -- economic growth has been healthy. That has been good news for fundamentals of real estate. There's some modest trend towards in-office or even office has some kind of backdrop momentum here. And overall, I think as you point out, we feel -- outside of office, we probably feel like we've kind of hit the trough, and we've probably seen a positive outlook. There's healthy fundamentals overall now for the economy. You have like some at least expectation of some declining interest rates. Even steepening of the curve, I think, would be a positive here. You're starting to see increasing t”